Analyst Reco. Repare Therapeutics Inc.

Equities

RPTX

US7602731025

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-25 EDT			5-day change	1st Jan Change
3.41 ^USD	-3.67%		-6.06%	-53.29%

06-12	Foundation Medicine Announces Partnership with Repare Therapeutics to Provide Genomic Profiling Services to Support Clinical Trials and to Develop Companion Diagnostic for Lunresertib	CI
06-10	Transcript : Repare Therapeutics Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 02:40 PM

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Repare Therapeutics Price Target to $10 From $25, Maintains Buy Rating	02-14	MT
Piper Sandler Cuts Repare Therapeutics' Price Target to $25 From $30, Keeps Overweight Rating	23-10-16	MT
Stifel Raises Repare Therapeutics' Price Target to $17 From $16, Keeps Buy Rating	23-09-25	MT
HC Wainwright Adjusts Price Target on Repare Therapeutics to $25 From $26, Keeps Buy Rating	23-08-17	MT
Stifel Upgrades Repare Therapeutics to Buy From Hold, Adjusts Price Target to $16 From $11	23-06-09	MT
HC Wainwright Adjusts Repare Therapeutics Price Target to $26 From $25, Maintains Buy Rating	23-06-09	MT
Morgan Stanley Adjusts Price Target on Repare Therapeutics to $14 From $15, Maintains Equal-Weight Rating	23-02-27	MT
Morgan Stanley Downgrades Repare Therapeutics to Equal Weight From Overweight, Adjusts Price Target to $15 From $28	23-02-03	MT
HC Wainwright Adjusts Repare Therapeutics' Price Target to $25 From $38, Keeps Buy Rating	22-11-17	MT
Morgan Stanley Adjusts Price Target on Repare Therapeutics to $28 From $30, Maintains Overweight Rating	22-08-08	MT
Berenberg Bank Adjusts Repare Therapeutics' Price Target to $31 From $34, Maintains Buy Rating	22-08-08	MT
Goldman Sachs Adjusts Price Target for Repare Therapeutics to $29 From $30, Maintains Buy Rating	22-08-05	MT
HC Wainwright Adjusts Repare Therapeutics' Price Target to $38 From $54, Keeps Buy Rating	22-06-06	MT
Piper Sandler Adjusts Repare Therapeutics' Price Target to $30 From $25, Keeps Overweight Rating	22-06-02	MT
Berenberg Bank USA Conference	22-05-22	FA
Berenberg Bank Adjusts Repare Therapeutics' Price Target to $34 From $51, Maintains Buy Rating	22-05-12	MT
Stifel Nicolaus Downgrades Repare Therapeutics to Hold From Buy, Adjusts Price Target to $11 From $45	22-04-12	MT
Piper Sandler Adjusts Price Target on Repare Therapeutics to $25 From $40, Reiterates Overweight Rating	22-04-12	MT
Northland Adjusts Repare Therapeutics' Price Target to $45 From $40, Keeps Outperform Rating	21-11-18	MT
REPARE THERAPEUTICS : Stifel Starts Repare Therapeutics at Buy With $48 Price Target	21-09-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Repare Therapeutics Inc.

Equities

RPTX

US7602731025

Analyst Reco.

Filters